Investigating the Efficacy and Safety of Oral Cicaglocal on Wound Healing After Mohs Surgery in Patients With Skin Cancer: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.16784 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Ali Asilian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Mohs Surgery, Wound Healing, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Mohs micrographic surgery is the gold standard treatment for skin cancers in cosmetically sensitive anatomic areas, with a cure rate close to 100%. Managing post‐Mohs surgery wounds can pose challenges, particularly in elderly patients. This study evaluates the Cicaglocal drug, a supplement with bromelain, Centella asiatica , hyaluronan, vitamins, and minerals, for enhancing wound healing post‐Mohs surgery.
Method
This double‐blinded, randomized clinical trial conducted at Al‐Zahra Hospital in 2023 involved 24 patients aged 50–80 with SCC or BCC undergoing Mohs surgery. Patients were randomized into two groups Cicaglocal and placebo. Treatments were administered postoperatively, and outcomes such as erythema reduction, early healing score (EHS), full recovery, and patient and physician satisfaction levels were evaluated 7 and 14 days after initiation. Data were collected through clinical assessments and standardized wound photographs.
Result
Oral Cicaglocal demonstrated significantly improved outcomes compared to their respective placebo groups in terms of erythema score, EHS, full recovery score, and patient and physician satisfaction levels.
Conclusion
Cicaglocal can enhance wound healing and lead to improved clinical outcomes following Mohs micrographic surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Dermatology, Skin and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Parisa Mohammadian, Reza Shahriarirad
Zitieren
APA
Asilian, A., Mohammadian, P., Mahram, H., Shahriarirad, R., & Bigham, M. (2025). Investigating the Efficacy and Safety of Oral Cicaglocal on Wound Healing After Mohs Surgery in Patients With Skin Cancer: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16784
Vancouver
Asilian A, Mohammadian P, Mahram H, Shahriarirad R, Bigham M. Investigating the Efficacy and Safety of Oral Cicaglocal on Wound Healing After Mohs Surgery in Patients With Skin Cancer: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16784
BibTeX
@article{Asilian2025,
author = {Asilian, Ali and Mohammadian, Parisa and Mahram, Hadiseh and Shahriarirad, Reza and Bigham, Mohammad},
title = {Investigating the Efficacy and Safety of Oral Cicaglocal on Wound Healing After Mohs Surgery in Patients With Skin Cancer: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.16784}
}
EUVIMED